NIH Patents and Patent Applications

This list includes non-provisional and PCT patent filings.

Download a CSV of all Patent records.

For information on patent application codes, country codes, and patent status, see the Patents FAQ.

Tips:
Reset Search to show all records.
Sort columns by clicking on the blue column headers.
The Search function searches across all columns.
To filter results by Lead IC, Country, or Application, type or use the dropdown menu.

Lead IC Reference Number Title Country Patent Application Type Application Number Date Filed Patent Number Date Issued Patent Status Patent PDF
NCATS E-072-2012-0-CH-06 Modulators Of The Relaxin Receptor 1 CH EP 13715054.6 Issued
NCATS E-072-2012-0-GB-10 Modulators Of The Relaxin Receptor 1 GB EP 13715054.6 Issued
NCATS E-072-2012-0-EP-03 Modulators Of The Relaxin Receptor 1 EP National Stage 13715054.6 Issued
NCI E-040-2012-0-IN-13 CHIMERIC ANTIGEN RECEPTORS TARGETING B CELL MATURATION ANTIGEN IN National Stage 7407/CHENP/2014 Issued
NCI E-040-2012-0-TJ-53 Chimeric Antigen Receptors Targeting B-cell Maturation Antigen TJ EA 201491837 Issued
NCI E-040-2012-0-TM-54 Chimeric Antigen Receptors Targeting B-cell Maturation Antigen TM EA 201491837 Issued
NCI E-040-2012-0-AM-48 Chimeric Antigen Receptors Targeting B-cell Maturation Antigen AM EA 201491837 Issued
NCI E-040-2012-0-BY-50 Chimeric Antigen Receptors Targeting B-cell Maturation Antigen BY EA 201491837 Issued
NCI E-040-2012-0-AZ-49 Chimeric Antigen Receptors Targeting B-cell Maturation Antigen AZ EA 201491837 Issued
NCI E-040-2012-0-KG-51 Chimeric Antigen Receptors Targeting B-cell Maturation Antigen KG EA 201491837 Issued
NCI E-040-2012-0-KZ-52 Chimeric Antigen Receptors Targeting B-cell Maturation Antigen KZ EA 201491837 Issued
NCI E-040-2012-0-EA-08 Chimeric Antigen Receptors Targeting B-cell Maturation Antigen EA National Stage 201491837 Issued
NCI E-264-2011-0-AU-03 Delivery Of Packaged RNA To Mammalian Cells AU National Stage 2013240248 Issued
NCI E-040-2012-0-AU-04 Chimeric Antigen Receptors Targeting B-cell Maturation Antigen AU National Stage 2013246443 Issued
NHLBI E-108-2010-0-US-04 Methods and Devices for Transcatheter Cerclage Annuloplasty US National Stage 13/824,198 9579200 Issued PDF
NIAAA E-070-2012-0-EP-03 Derivatives of Docosahexaenoylethanolamide and Uses Thereof EP National Stage 13714787.2 Issued
NCATS E-072-2012-0-PCT-02 Modulators Of The Relaxin Receptor 1 PCT PCT PCT/US13/32231 Expired
NCATS E-300-2012-0-PCT-01 Coincidence Reporter Gene System PCT PCT PCT/US2013/032184 Expired
NIAAA E-070-2012-0-PCT-02 Derivatives of Docosahexaenoylethanolamide and Uses Thereof PCT PCT PCT/US2013/032333 Expired
NCI E-040-2012-0-PCT-02 Chimeric Antigen Receptors Targeting B-cell Maturation Antigen PCT PCT PCT/US2013/032029 Expired
NCATS E-144-2012-2-PCT-01 SALICYLIC ACID DERIVATIVES USEFUL AS GLUCOCEREBROSIDASE ACTIVATORS PCT PCT COMB PCT/US13/32253 Expired
NCI E-264-2011-0-PCT-02 Novel Delivery Of Packaged RNA To Mammalian Cells PCT PCT PCT/US2013/031876 Expired
NIAID E-271-2012-1-PCT-01 Neutralizing Antibodies to HIV-1 and Their Use PCT PCT COMB PCT/US2013/032070 Expired
NCI E-056-2012-0-PCT-02 ZIRCONIUM-89 COMPLEXES, METHODS OF LABELING CELLS, LABELED CELLS, KITS, AND METHODS OF USE THEREOF PCT PCT PCT/US2013/031944 Expired
NCI E-025-2009-1-US-01 Ratio Based Biomarkers and Methods of Use Thereof US CIP 13/841,176 Abandoned
NCI E-040-2012-0-EP-09 Chimeric Antigen Receptors Targeting B-cell Maturation Antigen EP National Stage 13714125.5 Abandoned
NCI E-264-2011-0-EP-04 Delivery Of Packaged RNA To Mammalian Cells EP National Stage 13712661.1 Abandoned
NCATS E-144-2012-2-EP-04 SALICYLIC ACID DERIVATIVES USEFUL AS GLUCOCEREBROSIDASE ACTIVATORS EP National Stage 13713047.2 Abandoned
NIAID E-271-2012-1-EP-02 Neutralizing Antibodies to HIV-1 and Their Use EP National Stage 13763664.3 Abandoned
NCI E-035-2013-0-US-01 Inhibitors Of The Linear Ubiquitin Chain Assembly Complex (LUBAC) and Related Methods US 61/789,064 Abandoned
NCATS E-046-2013-1-US-01 Process For Synthesis Of Enantioenriched Aminoalcohols Containing A Tertiary Alcohol Fragment, And Derivatives Of Those Aminoalcohols Including The Co-crystal Of VT-1129 With Benzenesulfonic Acid (BSA). US 61/802,217 Abandoned
NIDA E-086-2013-0-US-01 High-Affinity Dopamine D3 Receptor Antagonists And Partial Agonist US 61/788,167 Abandoned
NCI E-065-2013-0-US-01 FKBP52 Targeting Agent Pharmaceutical Compositions US 61/788,716 Abandoned
NCATS E-083-2013-0-US-01 Measurement of Cellular FMRP Levels for High Throughput Drug Screening and Diagnosis of Fragile X Syndrome US 61/793,577 Abandoned
NIAID E-081-2013-1-US-01 PREFUSION RSV F PROTEINS AND THEIR USE US 61/798,389 Abandoned
NIA E-139-2012-1-US-01 Methods of Regulating Cannabinoid Receptor Activity-Related Disorders and Diseases US 61/789,629 Abandoned
CC E-184-2012-0-US-01 Synthesis And Characterization Of Image-able Polyvinyl Alcohol Microspheres For Chemoembolization And X-ray-based Imaging US 61/790,373 Abandoned
NCATS E-046-2013-3-US-01 Process For Synthesis Of Enantioenriched Aminoalcohols Containing A Tertiary Alcohol Fragment, And Derivatives Of Those Aminoalcohols Including The Co-crystal Of VT-1129 With Benzenesulfonic Acid (BSA). US 61/801,784 Abandoned
NCATS E-023-2013-0-US-01 NRF2 SMALL MOLECULE INHIBITORS FOR CANCER THERAPY US 61/798,843 Abandoned
NCATS E-046-2013-0-US-01 Process For Synthesis Of Enantioenriched Aminoalcohols Containing A Tertiary Alcohol Fragment, And Derivatives Of Those Aminoalcohols Including The Co-crystal Of VT-1129 With Benzenesulfonic Acid (BSA). US 61/802,071 Abandoned
NIAID E-080-2013-1-US-01 Attenuation of Human Respiratory Syncytial Virus By Genome Scale Codon-Pair Deoptimization US 61/794,155 Abandoned
NIMH E-448-2013-0-US-01 Method for Pediatric Acute-Onset Neurologic Syndrome (PANS) and Pediatric Autoimmune Neurologic Disorder Assocated with Streptococci (PANDAS) US 61/787,919 Abandoned
NHGRI E-243-2012-0-US-01 Synthetic Methylmalonyl-CoA Mutase Transgene For The Treatment Of Mut Class Methylmalonic Acidemia (MMA) US 61/792,081 Abandoned
NCI E-033-2013-0-US-01 Stabilized Single Human CD4 Domains And Fusion Proteins US 61/791,885 Abandoned
NCATS E-144-2012-2-AU-02 SALICYLIC ACID DERIVATIVES USEFUL AS GLUCOCEREBROSIDASE ACTIVATORS AU National Stage 2013240187 Abandoned
NCATS E-144-2012-2-CA-03 SALICYLIC ACID DERIVATIVES USEFUL AS GLUCOCEREBROSIDASE ACTIVATORS CA National Stage 2868484 Abandoned
NIAID E-117-2013-0-CN-01 ANTI-RSV HIGH NEURTRALIZATION ANTIBODY AND THE PEPTIDE CAN BE USED FOR PREVENTION OF RSV INFECTION AND RELATED DISEASE CN ORD 201310082338.1 Abandoned
NCI E-217-2011-1-CA-05 Novel Interferon-Lambda4 (IFNL4) Protein, Related Nucleic Acid Molecules, and Uses Thereof CA National Stage 2869899 Issued
NCI E-217-2011-1-CN-06 Novel Interferon-Lambda4 (IFNL4) Protein, Related Nucleic Acid Molecules, and Uses Thereof CN National Stage 201380028364.4 Issued
NCI E-217-2011-1-CH-13 Novel Interferon-Lambda4 (IFNL4) Protein, Related Nucleic Acid Molecules, and Uses Thereof CH EP 13712655.3 Issued